Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint

According to the ESC guidelines, cangrelor may be considered in P2Y12-inhibitor-naïve acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). The aim of this review is to summarize available evidence on the optimal maintenance therapy with P2Y12 receptor inhibitor...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Jacek Kubica, Piotr Adamski, Robert Gajda, Aldona Kubica, Małgorzata Ostrowska, Gavino Casu, Diana A. Gorog, Paul A. Gurbel, Tomasz Hajdukiewicz, Miłosz Jaguszewski, Young-Hoon Jeong, Agata Kosobucka-Ozdoba, Zuzana Motovska, Piotr Niezgoda, Maciej Piasecki, Przemysław Podhajski, Paolo Raggi, Uzeyir Rahimov, Jolanta M. Siller-Matula, Grzegorz Skonieczny, Łukasz Szarpak, Paweł Szymański, Udaya Tantry, Eliano P. Navarese
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Via Medica 2025-02-01
Sarja:	Cardiology Journal
Aiheet:	antiplatelet therapy cangrelor ticagrelor P2Y12 receptor inhibition
Linkit:	https://journals.viamedica.pl/cardiology_journal/article/view/98323
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!